1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Open Targets Platform ( https://platform.opentargets.org) is a unique, open-source, publicly-available knowledge base providing data and tooling for systematic drug target identification, annotation, and prioritisation. Since our last report, we have expanded the scope of the Platform through a number of significant enhancements and data updates, with the aim to enable our users to formulate more flexible and impactful therapeutic hypotheses. In this context, we have completely revamped our target–disease associations page with more interactive facets and built-in functionalities to empower users with additional control over their experience using the Platform, and added a new Target Prioritisation view. This enables users to prioritise targets based upon clinical precedence, tractability, doability and safety attributes. We have also implemented a direction of effect assessment for eight sources of target–disease association evidence, showing the effect of genetic variation on the function of a target is associated with risk or protection for a trait to inform on potential mechanisms of modulation suitable for disease treatment. These enhancements and the introduction of new back and front-end technologies to support them have increased the impact and usability of our resource within the drug discovery community.

          Graphical Abstract

          Graphical Abstract

          Related collections

          Most cited references60

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The mutational constraint spectrum quantified from variation in 141,456 humans

          Genetic variants that inactivate protein-coding genes are a powerful source of information about the phenotypic consequences of gene disruption: genes that are crucial for the function of an organism will be depleted of such variants in natural populations, whereas non-essential genes will tolerate their accumulation. However, predicted loss-of-function variants are enriched for annotation errors, and tend to be found at extremely low frequencies, so their analysis requires careful variant annotation and very large sample sizes 1 . Here we describe the aggregation of 125,748 exomes and 15,708 genomes from human sequencing studies into the Genome Aggregation Database (gnomAD). We identify 443,769 high-confidence predicted loss-of-function variants in this cohort after filtering for artefacts caused by sequencing and annotation errors. Using an improved model of human mutation rates, we classify human protein-coding genes along a spectrum that represents tolerance to inactivation, validate this classification using data from model organisms and engineered human cells, and show that it can be used to improve the power of gene discovery for both common and rare diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The FAIR Guiding Principles for scientific data management and stewardship

            There is an urgent need to improve the infrastructure supporting the reuse of scholarly data. A diverse set of stakeholders—representing academia, industry, funding agencies, and scholarly publishers—have come together to design and jointly endorse a concise and measureable set of principles that we refer to as the FAIR Data Principles. The intent is that these may act as a guideline for those wishing to enhance the reusability of their data holdings. Distinct from peer initiatives that focus on the human scholar, the FAIR Principles put specific emphasis on enhancing the ability of machines to automatically find and use the data, in addition to supporting its reuse by individuals. This Comment is the first formal publication of the FAIR Principles, and includes the rationale behind them, and some exemplar implementations in the community.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Attention Is All You Need

              The dominant sequence transduction models are based on complex recurrent or convolutional neural networks in an encoder-decoder configuration. The best performing models also connect the encoder and decoder through an attention mechanism. We propose a new simple network architecture, the Transformer, based solely on attention mechanisms, dispensing with recurrence and convolutions entirely. Experiments on two machine translation tasks show these models to be superior in quality while being more parallelizable and requiring significantly less time to train. Our model achieves 28.4 BLEU on the WMT 2014 English-to-German translation task, improving over the existing best results, including ensembles by over 2 BLEU. On the WMT 2014 English-to-French translation task, our model establishes a new single-model state-of-the-art BLEU score of 41.8 after training for 3.5 days on eight GPUs, a small fraction of the training costs of the best models from the literature. We show that the Transformer generalizes well to other tasks by applying it successfully to English constituency parsing both with large and limited training data. 15 pages, 5 figures
                Bookmark

                Author and article information

                Contributors
                Journal
                Nucleic Acids Res
                Nucleic Acids Res
                nar
                Nucleic Acids Research
                Oxford University Press
                0305-1048
                1362-4962
                06 January 2025
                06 December 2024
                06 December 2024
                : 53
                : D1
                : D1467-D1475
                Affiliations
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                AstraZeneca UK Limited
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Wellcome Sanger Institute, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SA, UK
                Open Targets, Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus , Hinxton, Cambridgeshire CB10 1SD, UK
                Author notes
                To whom correspondence should be addressed. Tel: +44 1223 494330; Email: emcdonagh@ 123456ebi.ac.uk
                Correspondence may also be addressed to David Ochoa. Tel: +44 1223 494330; Email: ochoa@ 123456ebi.ac.uk
                Author information
                https://orcid.org/0000-0002-4623-8642
                https://orcid.org/0000-0002-7368-180X
                https://orcid.org/0000-0003-2525-5598
                https://orcid.org/0000-0001-5806-6174
                https://orcid.org/0000-0003-1857-278X
                Article
                gkae1128
                10.1093/nar/gkae1128
                11701534
                39657122
                d3fa9e6e-f7b3-4699-b96d-c8bf89f06bc7
                © The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 30 October 2024
                : 23 October 2024
                : 13 September 2024
                Page count
                Pages: 9
                Funding
                Funded by: Wellcome Trust, DOI 10.13039/100010269;
                Award ID: 206194
                Funded by: Open Targets;
                Categories
                AcademicSubjects/SCI00010
                Database Issue

                Genetics
                Genetics

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content51

                Cited by3

                Most referenced authors4,030